A watershed year? 2022 sees cannabis on the rise, while CBD goes downhill

This past year has seen a curious crossing of paths in the world of cannabis and cannabinoids. Concerns around CBD, typically considered the “safest” cannabinoid and the one derived from widely legal hemp, have only increased. Whereas concerns over cannabis itself continue to be minimised as more and more jurisdictions come to support it for medical and even recreational purposes.

Sometimes, confusingly, this has even been happening in the same countries.

Read full article
I'm already a subscriber

Freddie Dawson

Senior news editor
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the ECigIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization